Ticker
DTC
Ownership
Defence Therapeutics Inc Class A Ownership
Ownership for Defence Therapeutics Inc Class A (DTC) on 6ix covers company data, market context, news, risks, and AI research briefs.
Defence Therapeutics Inc Class A
Defence Therapeutics Inc Class A investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to DTC.
Stock profile
Asset type
Stock
Market cap
$25.2M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Currency
CAD
Ticker listings
Defence Therapeutics Inc Class A may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
- DTC primary listing
- DTCFF
- A3CN14
Research sections
Valuation
Review valuation context for Defence Therapeutics Inc Class A.
Future growth
Review future growth context for Defence Therapeutics Inc Class A.
Past performance
Review past performance context for Defence Therapeutics Inc Class A.
Financial health
Review financial health context for Defence Therapeutics Inc Class A.
Dividend
Review dividend context for Defence Therapeutics Inc Class A.
Management
Review management context for Defence Therapeutics Inc Class A.
Ownership
Review ownership context for Defence Therapeutics Inc Class A.
Other information
Review other information context for Defence Therapeutics Inc Class A.
Community
Review community context for Defence Therapeutics Inc Class A.